We are pleased to announce that Theramir Limited has received the ‘Innovative SME’ certificate by the Ministry of Finance of the Republic of Cyprus, recognizing the company’s focus on innovation in the rapidly evolving field of precision oncology. Theramir was founded in 2017 in order to develop novel targeted therapies as part of a personalized medicine approach in the treatment of cancer disease, and is only the 2nd Cyprus based SME to be awarded the “Innovative SME” distinction. The certification, among other benefits, will allow prospective investors in Theramir to take advantage of the tax incentives for investments in innovative companies by claiming a tax deduction for the full amount of their investment (for up to 150K Euro per year). Innovative, research-intensive SMEs can also apply for grants of up to 2.5 million Euros for research and development projects through the EU’s Horizon 2020 program, while additional access to finance is available through local banks that offer Financial Risk-Sharing Products with the support of the European Investment Bank.